1. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures
    Tetsuya Magara et al, 2023, Frontiers in Oncology CrossRef
  2. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma
    Ying Xiong et al, 2017, Oncotarget CrossRef
  3. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma
    Lingxiang Wang et al, 2020, Medicine CrossRef
  4. B cell and B cell-related pathways for novel cancer treatments
    Ryuma Tokunaga et al, 2019, Cancer Treatment Reviews CrossRef
  5. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer
    Yu-Ming Rong et al, 2018, World Journal of Gastroenterology CrossRef
  6. Tertiary lymphoid structure and B‑cell‑related pathways: A potential target in tumor immunotherapy (Review)
    Meng Qin et al, 2021, Oncology Letters CrossRef
  7. Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma
    Atsushi Otsuka et al, 2015, Clinical Cancer Research CrossRef
  8. Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas
    Daiqiang Li et al, 2020, Applied Immunohistochemistry & Molecular Morphology CrossRef
  9. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer
    Xiaosheng He et al, 2017, Virchows Archiv CrossRef
  10. Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer
    Xiaosheng He et al, 2016, Tumor Biology CrossRef
  11. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment
    Bowen Chen et al, 2020, Bioscience Reports CrossRef
  12. In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity
    Hasan Marashi et al, 2022, PLOS ONE CrossRef